Press release
Increase In Alcohol Consumption Driving Growth Of The Market Due To Rising Alcohol-induced Gastric Issues: A Significant Driver Propelling The Functional Dyspepsia Drug Market In 2025
Functional Dyspepsia Drug
What Is the Functional Dyspepsia Drug Market Size and Projected Growth Rate?
The market for drugs treating functional dyspepsia has witnessed substantial expansion in the past few years. The market size is projected to surge from $8.56 billion in 2024 to about $9.15 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. This robust growth during the previous years can be linked to a variety of contributing factors such as increased occurrences of various associated risk conditions, escalated healthcare spending, growth in dyspeptic case numbers, a surge in gastrointestinal disorders, and the expanding elderly population.
The market size of drugs for functional dyspepsia is predicted to witness robust growth in the coming years. The prediction anticipates that the market will reach the valuation of $11.80 billion by 2029, progressing at a compound annual growth rate (CAGR) of 6.6%. This projected growth during the forecast period is largely attributable to the rise in consumer inclination towards more comprehensive and lifestyle-oriented solutions, the escalating preference for combination treatments, an increased tendency towards lifestyle adaptation, more research on the gut-brain relationship, and a growing trend of using non-drug interventions. The forecast period is also expected to see key trends such as progress in drug formulation, partnerships between healthcare providers and pharmaceutical firms, a movement towards precision medicine, the incorporation of telemedicine and digital healthcare technologies, and the rise of personalized medicine practices.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21979
What Are the Major Segments in the Functional Dyspepsia Drug Market?
The functional dyspepsia drug market covered in this report is segmented -
1) By Drug Type: Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics, Prokinetics, Antidepressants
2) By Indication: Functional Dyspepsia, Organic Dyspepsia
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
2) By H-2-Receptor Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Aluminum Hydroxide, Magnesium Hydroxide, Calcium Carbonate, Sodium Bicarbonate
4) By Antibiotics: Clarithromycin, Amoxicillin, Metronidazole, Tetracycline
5) By Prokinetics: Domperidone, Metoclopramide, Itopride, Mosapride
6) By Antidepressants: Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21979&type=smp
What Are The Driving Functional Dyspepsia Drug Market Evolution?
The surge in alcohol consumption is anticipated to fuel the upturn of the functional dyspepsia drug market. Alcohol, a fundamental organic compound in beverages such as wine, beer, and spirits, primarily contains ethanol that impacts the central nervous system and evokes intoxication when ingested. The escalating alcohol consumption can be attributed to social and cultural acceptance, stress management, accessibility, and vigorous promotion by alcoholic beverage firms. Drugs addressing functional dyspepsia can serve to reduce acid production and improve digestion, thereby mitigating alcohol-triggered gastric distress. As per a report released by the Office for Health Improvement & Disparities (OHID), a UK government body, in March 2023, hospital admissions due to alcohol ranged to 342,795 between 2021-2022, achieving a ratio of 626 admissions per 100,000 people. This burgeoning alcohol consumption is therefore capacitating the growth of the functional dyspepsia drug market. The burgeoning instances of metabolic disorders are anticipated to fuel the progress of the functional dyspepsia drug market. Metabolic disorders occur when the body's standard metabolic processes are upset resulting in nutrient processing, energy, or waste imbalances. Factors such as unhealthy diets, inactive lifestyles, genetic predispositions, and bulging obesity rates spearhead the intensifying prevalence of metabolic disorders. Drugs combating functional dyspepsia are used to control gastrointestinal symptoms and boost digestive function in patients with metabolic disorders. As stated by the World Health Organization (WHO), a Switzerland-based government entity, in a report released in November 2024, by 2022, about 14% of the adult population aged 18 and older were diagnosed with diabetes. Consequently, this mounting prevalence of metabolic disorders propels the growth of the functional dyspepsia drug market.
Which Firms Dominate The Functional Dyspepsia Drug Market Segments?
Major companies operating in the functional dyspepsia drug market are Pfizer Inc., Abbvie Inc., Bayer AG, AstraZeneca plc, Astellas Pharma Inc., Eisai Co. Ltd., Menarini Group, Dr. Reddy's Laboratories Ltd., Lupin Limited, Daewoong Pharmaceutical Co. Ltd., Phathom Pharmaceuticals, Zeria Pharmaceutical Co. Ltd., Ironwood Pharmaceuticals Inc., Salix Pharmaceuticals Inc., RedHill Biopharma, RaQualia Pharma Inc., MetaMe Health, Renexxion LLC, Processa Pharmaceuticals, Evoke Pharma Inc.
What Trends Are Expected to Dominate the Functional Dyspepsia Drug Market in the Next 5 Years?
Prominent organizations in the functional dyspepsia drug market are concentrating their efforts on carrying out clinical trials to create groundbreaking treatments designed to tackle the root causes of the disorder, improve the effectiveness of treatments, and fulfill unmet needs of patients. In order to evaluate safety, efficiency, and the best therapeutic strategies, clinical trials are a crucial part of developing drugs for functional dyspepsia. For example, in December 2022, medical tech firm electroCore Inc., based in the US, disclosed that the United States Patent and Trademark Office (USPTO) had sanctioned two patents tied to its unique non-invasive vagus nerve stimulation (nVNS) technology. The initial patent, U.S. Patent No. 11,511,109, defined a procedure for treating ailments of the gut, including functional dyspepsia, using vagus nerve stimulation. The subsequent patent, U.S. Patent No. 11,511,110, outlined a system to deliver non-invasive electric stimulation to the vagus nerve. These patents solidified electroCore's progressive stance in evolving non-invasive neuromodulation therapies.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/functional-dyspepsia-drug-global-market-report
Which Is The Largest Region In The Functional Dyspepsia Drug Market?
North America was the largest region in the functional dyspepsia drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the functional dyspepsia drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Functional Dyspepsia Drug Market?
2. What is the CAGR expected in the Functional Dyspepsia Drug Market?
3. What Are the Key Innovations Transforming the Functional Dyspepsia Drug Industry?
4. Which Region Is Leading the Functional Dyspepsia Drug Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increase In Alcohol Consumption Driving Growth Of The Market Due To Rising Alcohol-induced Gastric Issues: A Significant Driver Propelling The Functional Dyspepsia Drug Market In 2025 here
News-ID: 4073264 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
